Birchview Capital as of June 30, 2019
Portfolio Holdings for Birchview Capital
Birchview Capital holds 54 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 39.2 | $65M | 698k | 92.44 | |
| Accelr8 Technology | 30.4 | $50M | 2.2M | 22.88 | |
| Array BioPharma | 4.7 | $7.8M | 168k | 46.33 | |
| Neurocrine Biosciences (NBIX) | 2.8 | $4.6M | 55k | 84.44 | |
| Quidel Corporation | 1.8 | $2.9M | 49k | 59.31 | |
| Vermillion | 1.7 | $2.8M | 3.1M | 0.89 | |
| Eqt Midstream Partners | 1.4 | $2.2M | 50k | 44.68 | |
| Bristol Myers Squibb (BMY) | 1.2 | $2.0M | 44k | 45.34 | |
| Oxford Immunotec Global | 1.2 | $1.9M | 140k | 13.76 | |
| Harrow Health (HROW) | 0.9 | $1.6M | 180k | 8.70 | |
| Arena Pharmaceuticals | 0.8 | $1.3M | 22k | 58.64 | |
| Albireo Pharma | 0.8 | $1.2M | 38k | 32.24 | |
| G1 Therapeutics | 0.8 | $1.2M | 40k | 30.65 | |
| Masimo Corporation (MASI) | 0.7 | $1.2M | 8.0k | 148.88 | |
| Biogen Idec (BIIB) | 0.7 | $1.2M | 5.0k | 233.80 | |
| Amarin Corporation | 0.7 | $1.1M | 59k | 19.39 | |
| Dermira | 0.7 | $1.1M | 120k | 9.56 | |
| Vanda Pharmaceuticals (VNDA) | 0.7 | $1.1M | 80k | 14.09 | |
| Wright Medical | 0.5 | $895k | 30k | 29.83 | |
| Veracyte (VCYT) | 0.5 | $877k | 31k | 28.50 | |
| Voyager Therapeutics (VYGR) | 0.5 | $817k | 30k | 27.23 | |
| Acceleron Pharma | 0.5 | $767k | 19k | 41.08 | |
| Odonate Therapeutics Ord | 0.5 | $734k | 20k | 36.70 | |
| Dicerna Pharmaceuticals | 0.4 | $709k | 45k | 15.76 | |
| Dova Pharmaceuticals | 0.4 | $705k | 50k | 14.10 | |
| Soleno Therapeutics | 0.4 | $674k | 241k | 2.80 | |
| Intercept Pharmaceuticals In | 0.4 | $660k | 8.3k | 79.52 | |
| Arvinas Ord (ARVN) | 0.4 | $660k | 30k | 22.00 | |
| Pioneer Natural Resources | 0.4 | $585k | 3.8k | 153.95 | |
| Myriad Genetics (MYGN) | 0.3 | $556k | 20k | 27.80 | |
| Corcept Therapeutics Incorporated (CORT) | 0.3 | $558k | 50k | 11.16 | |
| Xencor (XNCR) | 0.3 | $503k | 12k | 40.89 | |
| Lexicon Pharmaceuticals (LXRX) | 0.3 | $503k | 80k | 6.29 | |
| Amicus Therapeutics (FOLD) | 0.3 | $474k | 38k | 12.47 | |
| Karyopharm Therapeutics | 0.3 | $419k | 70k | 5.99 | |
| ImmunoGen | 0.2 | $391k | 180k | 2.17 | |
| Atara Biotherapeutics | 0.2 | $402k | 20k | 20.10 | |
| Nektar Therapeutics | 0.2 | $338k | 9.5k | 35.58 | |
| Continental Resources | 0.2 | $337k | 8.0k | 42.12 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $267k | 10k | 26.70 | |
| Encana Corp | 0.1 | $244k | 48k | 5.14 | |
| Sientra | 0.1 | $246k | 40k | 6.15 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $203k | 8.0k | 25.38 | |
| EQT Corporation (EQT) | 0.1 | $179k | 11k | 15.84 | |
| Tg Therapeutics (TGTX) | 0.1 | $130k | 15k | 8.67 | |
| Cytokinetics (CYTK) | 0.1 | $113k | 10k | 11.30 | |
| Contrafect | 0.1 | $123k | 240k | 0.51 | |
| Yield10 Bioscience | 0.1 | $120k | 124k | 0.97 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.1 | $120k | 48k | 2.52 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $76k | 20k | 3.80 | |
| Xbiotech (XBIT) | 0.1 | $76k | 10k | 7.60 | |
| Workhorse Group Inc ordinary shares | 0.1 | $74k | 25k | 2.96 | |
| Livent Corp | 0.0 | $69k | 10k | 6.90 | |
| Aevi Genomic | 0.0 | $21k | 128k | 0.16 |
